slc25a39 glutathione

slc25a39 glutathione identified as a key regulator of hepatocellular carcinoma progression through the mitochondrial ROS–cytochrome c–caspase signaling axis | Cellular & Molecular Biology Letters SLC25A39 links mitochondrial GSH sensing

Name: slc25a39 glutathione identified as a key regulator of hepatocellular carcinoma progression through the mitochondrial ROS–cytochrome c–caspase signaling axis | Cellular & Molecular Biology Letters SLC25A39 links mitochondrial GSH sensing
Brand: astonvaughan.co.uk
SKU: 955294571
Price: 28.56 USD
Availability: InStock
Rating: 4.7614 (21 reviews)

SLC25A39 links mitochondrial GSH sensing with iron metabolism: Molecular Cell glutathione mode of action Controlling entry into mitochondria: potential roles for SLC25A39 in health and (treatment of) disease The glutathione redox cycle illustrating Up regulated SLC25A39 promotes cell growth and metastasis via regulating ROS production in colorectal cancer Autoregulatory control of mitochondrial glutathione homeostasis Science

SKU: 955294571 · From astonvaughan.co.uk

4.8

USD28.56 USD59.56

Pay in 4 interest-free payments of $7.14 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis

Glutathione deficiency is associated with age-related diseases, including Alzheimer's disease, cancer, liver disease, diabetes, and others

Investigation into early cognitive decline as a treatable condition is relevant to a wide range of cognitive impairment conditions, since mild age-related neuropathology increases risk for more severe neuropathology and dementia associated with Alzheimers Disease